|
DPAGT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.117600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.107900E-02 |
| Normal-vs-Stage2 |
7.206200E-01 |
| Normal-vs-Stage3 |
8.14270000000228E-05 |
| Normal-vs-Stage4 |
7.185300E-04 |
| Stage1-vs-Stage2 |
1.643590E-01 |
| Stage1-vs-Stage3 |
4.798000E-03 |
| Stage1-vs-Stage4 |
2.512200E-02 |
| Stage2-vs-Stage3 |
2.415600E-03 |
| Stage2-vs-Stage4 |
1.069710E-02 |
| Stage3-vs-Stage4 |
8.992200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.839500E-04 |
| Normal-vs-AfricanAmerican |
3.800300E-02 |
| Normal-vs-Asian |
1.656360E-01 |
| Caucasian-vs-AfricanAmerican |
9.447800E-01 |
| Caucasian-vs-Asian |
1.816590E-01 |
| AfricanAmerican-vs-Asian |
3.554400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.811700E-04 |
| Normal-vs-Female |
7.757500E-03 |
| Male-vs-Female |
1.179420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.466180E-02 |
| Normal-vs-Age(41-60Yrs) |
7.238800E-03 |
| Normal-vs-Age(61-80Yrs) |
7.722400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.568300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.008600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.280400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.505800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.216000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.327600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.155400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.95350000000195E-05 |
| Classical-VS-Follicular |
6.891800E-02 |
| Classical-VS-Other |
3.397400E-01 |
| Classical-VS-Normal |
7.875200E-03 |
| Tall-VS-Follicular |
1.5567899999902E-05 |
| Tall-VS-Other |
6.359000E-01 |
| Tall-VS-Normal |
2.08300000026362E-07 |
| Follicular-VS-Other |
2.020600E-01 |
| Follicular-VS-Normal |
5.153000E-01 |
| Other-VS-Normal |
3.270100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.130000E-02 |
| Normal-vs-N1 |
1.01959999998513E-06 |
| N0-vs-N1 |
5.228800E-04 |
|
|
